Fulcrum Therapeutics reported cash from operations of -$16.04M and free cash flow of -$16.15M for the quarter ended Jun 2026, down 16.1% year over year. This cash flow statement covers 33 quarters of results from Jun 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||||||||||||||
| Net Income | -20.72M | -24.09M | -26.69M | -34.21M | -23.74M | -26.14M | -27.79M | -27.84M | -24.02M | -24.76M | -30.13M | 52.56M | -21.70M | -16.57M | -20.46M | -17.30M | -19.59M | -20.33M | -22.87M | -26.18M | |||||||||||||
| Share-based Compensation | 4.96M | 3.79M | 6.53M | 6.14M | 5.93M | 3.27M | 6.88M | 10.11M | 10.11M | 3.45M | 12.29M | 12.55M | 10.75M | 2.48M | 12.01M | 70.67M | 69.49M | 3.07M | 90.09M | 22.30M | |||||||||||||
| Asset Writedowns and Impairment | 5.09M | ||||||||||||||||||||||||||||||||
| Cash from Operations | -22.57M | -21.86M | -22.11M | -27.37M | -27.88M | -19.70M | -24.12M | -20.79M | -22.91M | -23.16M | -25.28M | 58.90M | -19.07M | -16.76M | -15.26M | -13.82M | -14.19M | -16.80M | -18.75M | -16.04M | |||||||||||||
| Depreciation, Depletion & Amortization | |||||||||||||||||||||||||||||||||
| Amortizatization of Intangibles | -0.09M | -0.39M | -0.35M | -0.29M | -0.11M | 0.60M | 1.37M | 1.71M | 1.58M | 1.33M | 1.16M | 1.13M | 1.15M | 0.94M | 0.90M | 1.08M | 0.59M | 0.38M | 0.77M | 0.81M | |||||||||||||
| Change in Working Capital | |||||||||||||||||||||||||||||||||
| Change in Receivables | 2.61M | 2.50M | -0.36M | 0.34M | -4.99M | -0.13M | 0.56M | -0.08M | -0.04M | -0.54M | 2.33M | 1.32M | -1.56M | -1.12M | -0.98M | ||||||||||||||||||
| Change in Account Payables | -0.82M | 1.18M | 0.51M | -0.04M | -2.55M | 0.90M | 0.09M | 0.16M | -0.29M | -0.82M | 1.10M | -0.29M | 0.30M | -2.70M | 0.34M | 0.24M | 0.95M | -1.10M | 0.86M | 0.97M | |||||||||||||
| Change in Accured Expenses | 2.35M | -0.80M | -2.40M | 5.84M | -4.46M | 1.56M | -2.20M | 0.77M | -0.31M | 0.91M | -3.92M | 2.23M | 1.30M | -0.64M | -3.34M | 0.59M | 1.49M | 2.29M | -3.77M | -1.05M | |||||||||||||
| Other Working Capital Changes | -3.77M | -1.42M | -1.79M | -1.14M | -0.39M | -0.46M | 0.52M | -0.94M | -0.18M | 1.67M | -0.80M | -0.46M | 2.42M | 0.21M | -1.83M | 0.29M | -0.04M | -0.04M | 0.18M | -2.24M | |||||||||||||
| Investing Activities | |||||||||||||||||||||||||||||||||
| Capital Expenditures | 0.37M | 0.52M | 0.85M | 0.72M | 0.28M | 0.12M | 0.17M | 0.20M | 0.07M | 0.08M | 0.03M | 0.15M | 0.10M | 0.07M | 0.09M | 0.15M | 0.01M | 0.11M | |||||||||||||||
| Change in Acquisitions & Divestments | 23.30M | 26.31M | 24.89M | 42.89M | 50.70M | 47.04M | 32.73M | 37.40M | 45.07M | 43.51M | 93.97M | 50.73M | 42.50M | 23.90M | 59.62M | 90.39M | 35.99M | 25.25M | 27.14M | 37.65M | |||||||||||||
| Cash from Investing Activities | -106.64M | -9.09M | 19.66M | 31.39M | -2.28M | -36.36M | -93.94M | 19.88M | 19.02M | 18.35M | 38.13M | -12.51M | 4.35M | 2.26M | -0.78M | 13.93M | 18.61M | -1.05M | -128.21M | 13.78M | |||||||||||||
| Financing Activities | |||||||||||||||||||||||||||||||||
| Other financing activities | |||||||||||||||||||||||||||||||||
| Change in Capital Stock | |||||||||||||||||||||||||||||||||
| Net Shares Issued and Repurchased | 2.98M | 1.61M | 3.71M | 1.74M | 6.09M | 2.63M | 4.42M | 2.89M | 4.18M | 2.40M | |||||||||||||||||||||||
| Net Equity Issued and Repurchased | 2.38M | 0.97M | 0.35M | 2.81M | 0.09M | 0.27M | 0.35M | 0.14M | 0.29M | 1.65M | 0.38M | 0.64M | 0.08M | 0.30M | 0.06M | 3.80M | 0.02M | 0.36M | |||||||||||||||
| Misc. | |||||||||||||||||||||||||||||||||
| Cash from Financing Activities | 137.90M | 0.89M | 0.35M | 2.81M | 80.95M | 0.22M | 117.69M | 0.14M | 0.29M | 1.65M | 0.38M | 0.64M | 0.08M | 0.30M | 0.06M | 168.30M | -0.31M | 0.36M | |||||||||||||||
| Change in Cash | 8.69M | -30.06M | -2.10M | 6.84M | 50.78M | -55.84M | -0.36M | -0.77M | -3.89M | -4.52M | 14.49M | 46.77M | -14.09M | -14.42M | -16.03M | 0.41M | 4.49M | 150.46M | -147.27M | -1.90M | |||||||||||||
| Free Cash Flow | -22.94M | -22.38M | -22.95M | -28.08M | -28.16M | -19.81M | -24.29M | -20.98M | -22.97M | -23.23M | -25.31M | 58.90M | -19.22M | -16.86M | -15.26M | -13.88M | -14.28M | -16.95M | -18.76M | -16.15M | |||||||||||||
| Net Cash Flow | 8.69M | -30.06M | -2.10M | 6.84M | 50.78M | -55.84M | -0.36M | -0.77M | -3.89M | -4.52M | 14.49M | 46.77M | -14.09M | -14.42M | -16.03M | 0.41M | 4.49M | 150.46M | -147.27M | -1.90M |